Meeting with the U.S. FDA Center for Biologics Evaluation and Research

A meeting between representatives of the EC and FDA took place in March 2018 to share preliminary findings of the EU Evaluation and to exchange views with the FDA on the issues raised through a stakeholder consultation. Minutes of the Meeting can be accessed at :